Deletion Mutants of Phagosomal Transporters FptA and FptF Are Highly Attenuated for Virulence and Are Protective Against Lethal Intranasal LVS Challenge in a Murine Model of Respiratory Tularemia
AuthorHobbs, Brandi E
Matson, Courtney A
Theofilou, Vasileios I
Webb, Tonya J
Younis, Rania H
Barry, Eileen M
JournalPathogens (Basel, Switzerland)
MetadataShow full item record
AbstractFrancisella tularensis (Ft) is a Gram-negative, facultative intracellular bacterium that is a Tier 1 Select Agent of concern for biodefense for which there is no licensed vaccine. A subfamily of 9 Francisella phagosomal transporter (fpt) genes belonging to the Major Facilitator Superfamily of transporters was identified as critical to pathogenesis and potential targets for attenuation and vaccine development. We evaluated the attenuation and protective capacity of LVS derivatives with deletions of the fptA and fptF genes in the C57BL/6J mouse model of respiratory tularemia. LVSΔfptA and LVSΔfptF were highly attenuated with LD50 values of >20 times that of LVS when administered intranasally and conferred 100% protection against lethal challenge. Immune responses to the fpt mutant strains in mouse lungs on day 6 post-infection were substantially modified compared to LVS and were associated with reduced organ burdens and reduced pathology. The immune responses to LVSΔfptA and LVSΔfptF were characterized by decreased levels of IL-10 and IL-1β in the BALF versus LVS, and increased numbers of B cells, αβ and γδ T cells, NK cells, and DCs versus LVS. These results support a fundamental requirement for FptA and FptF in the pathogenesis of Ft and the modulation of the host immune response.
Live Vaccine Strain (LVS)
live attenuated vaccine
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/16199
- Members of the Francisella tularensis phagosomal transporter subfamily of major facilitator superfamily transporters are critical for pathogenesis.
- Authors: Marohn ME, Santiago AE, Shirey KA, Lipsky M, Vogel SN, Barry EM
- Issue date: 2012 Jul
- Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent <i>F. tularensis</i> subsp. <i>tularensis</i>.
- Authors: Jia Q, Horwitz MA
- Issue date: 2018
- Deletion of the Major Facilitator Superfamily Transporter <i>fptB</i> Alters Host Cell Interactions and Attenuates Virulence of Type A Francisella tularensis.
- Authors: Balzano PM, Cunningham AL, Grassel C, Barry EM
- Issue date: 2018 Mar
- Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
- Authors: Baron SD, Singh R, Metzger DW
- Issue date: 2007 May
- Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
- Authors: KuoLee R, Harris G, Conlan JW, Chen W
- Issue date: 2007 May 10